Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade TrendingStockAlerts · Nov 6, 2025
Natural Field will Launch "Ashwagandha White Paper" at FTA Forum in Hangzhou TrendingStockAlerts · Nov 5, 2025
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine' TrendingStockAlerts · Nov 4, 2025
Zhimeng Biopharma's investigational drug CB03-154 for amyotrophic lateral sclerosis has achieved the first patient first dose milestone in the phase 2/3 pivotal clinical trial. TrendingStockAlerts · Nov 3, 2025
StimLabs® Announces New Real-World Study Demonstrating Positive Outcomes Using Relese® in the Treatment of Chronic Wounds TrendingStockAlerts · Nov 2, 2025
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger TrendingStockAlerts · Nov 1, 2025
Hansa Biopharma Reports Third Quarter and Interim Year to Date 2025 Financial Results TrendingStockAlerts · Oct 31, 2025
NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares TrendingStockAlerts · Oct 30, 2025
NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem TrendingStockAlerts · Oct 29, 2025
Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets TrendingStockAlerts · Oct 28, 2025
Published in The Lancet: Nipocalimab significantly decreased Sjögren's disease (SjD) activity and severity through substantial reduction in Sjögren's-related autoantibodies TrendingStockAlerts · Oct 27, 2025
